All News #Library
Biotech
Kelun-Biotech`s SKB264 Study Results Presented At CSCO Congress
28 Sep 2024 //
PR NEWSWIRE
Kelun-Biotech Releases Three SKB264 Study Abstracts At ESMO 2024
09 Sep 2024 //
PR NEWSWIRE
Merck Bags Kelun ADC For $37.5M, Boots Out Another Asset
20 Aug 2024 //
FIERCE BIOTECH
Kelun-Biotech`s TROP2-ADC SKB264 Gets Second NDA Accepted In China
20 Aug 2024 //
PR NEWSWIRE

Market Place
Sourcing Support